FDA Inspection 834497 — Lawrence Werlin MD, Inc.

Lawrence Werlin MD, Inc. — FEI 3005605711

The FDA completed an inspection of Lawrence Werlin MD, Inc. on Jun 7, 2013 in Irvine, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 7, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Irvine, CA (United States)

Citations

IDCFRDescription
1222121 CFR 1271.47(a)Procedures for all other requirements